[1] | Asvold B.O., Vatten L.J., Nilsen T.I. and Bjoro T. (2007): The association between TSH within the reference range and serum lipid concentrations in a population-based study. The HUNT Study. Eur J Endocrinol; 156:181–6. |
[2] | Rizos C.V, Elisaf M.S, and Liberopoulos E.N (2011): Effects of Thyroid Dysfunction on Lipid Profile. Open Cardiovasc Med J.; 5: 76–84. |
[3] | Ouchi N., Parker J.L., Lugus J.J. and et al. (2011): Adipokines in inflammation andmetabolic disease. Nat Rev Immunol.; 11:85–97. |
[4] | Rabe K., lehrke M., parhofer K.G. and Broedl U. (2008): Adipokines and insulin resistance. Mol Med; 14:741-51. |
[5] | Yu S., Zhang Y., Li M.Z., Xu H. and at al. (2012): Chemerin and apelin are positively correlated with inflammation in obese type 2 diabetic patients. Chin Med J; 125:3440-3444. |
[6] | Landgraf K., Friebe D., Ullrich T., Kratzsch J. and at al. (2012): Chemerin as a mediator between obesity and vascular inflammation in children. J ClinEndocrinolMetab; 97: E556-564. |
[7] | Luangsay S., Wittamer V., Bondue B. and et al. (2009): Mouse ChemR23 is expressed in dendritic cell subsets and macrophages, and mediates an anti-inflammatory activity of chemerin in a lung disease model. J Immunol.; 183: 6489–99. |
[8] | Wittamer V., Franssen J.D., Vulcano M. and et al. (2003): Specific recruitment of antigen-presenting cells by chemerin, a novel processed ligand from human inflammatory fluids. J Exp Med.; 198: 977–85. |
[9] | Miehle K., Ebert T., Kralisch S., Hoffmann A. and et al. (2016): Circulating serum chemerin levels are elevated in lipodystrophy. Clinical Endocrinology; 84: 932–938. |
[10] | Bell A., Gagnon A., Grunder L., Parikh S.J., Smith T.J. and Sorisky A. (2000): Functional TSH receptor in human abdominal preadipocytes and orbital fibroblasts. American Journal of Physiology: Cell Physiology; 279: C335–C340. |
[11] | Aydogan B.İ. and Sahin M. (2013): Adipocytokines in thyroid dysfunction. ISRN Inflamm. 2013: 1-7. |
[12] | Ahren B. and Scheurink A.J.W. (1998): Marked hyperleptinemia after high fat diet associated with severe glucose intolerance in mice. Eur J Endocrinol; 139: 461-7. |
[13] | Ferreira E., Silva A.E., Serakides R., Gomes A.E.S. and Cassali G.D. (2007): Model of induction of thyroid dysfunctions in adult female mice. Arq. Bras. Med. Vet. Zootec.; 59(5): 1245-1249. |
[14] | Novelli E., Diniz Y., Galhardi C., et al. (2007): Anthropometrical parameters and markers of obesity in rats Laboratory Animals Ltd. Laboratory Animals; 41:111–119. |
[15] | Reinehr T. (2010): Obesity and thyroid function. Molecular and Cellular Endocrinology; 316:165-171. |
[16] | Boyuk B., Guzel E.C., Atalay H., SavasGuzel S. and et al. (2015): Relationship between plasma chemerin levels and disease severity in COPD patients. ClinRespir J.; 9(4): 468-74. |
[17] | Allain C., Poon L.S., Chan C.S., Richmond. W., Fu PC. (1974): Enzymatic determination of total serum cholesterol. ClinChem; 20: 470-5. |
[18] | Naito H.K. (1989): Triglycerides in clinical chemistry: theory, analysis and correlation. Second edition by Kaplan LA and Pesce AJ. (U.S.A.), P. 997. |
[19] | Warnick G.R., Benderson V. and Albers N. (1983): Selected methods. ClinChem; 10:91-9. |
[20] | Friedwald W.T., Levy R.I. and Fredrickson D.S. (1972): Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. ClinChem; 18:499-502. |
[21] | Kennedy A.J. and Davenport A.P. (2018): International Union of Basic and Clinical Pharmacology CIII: Chemerin Receptors CMKLR1 (Chemerin1) and GPR1 (Chemerin2) Nomenclature, Pharmacology, and Function. Pharmacol Rev; 70:174–196. |
[22] | Yu S., Zhang Y., Li M.Z., Xu H. and et al. (2012): Chemerin and apelin are positively correlated with inflammation in obese type 2 diabetic patients. Chin Med J (Engl); 125: 3440-3444. |
[23] | Landgraf K., Friebe D., Ullrich T., Kratzsch J. and et al. (2012): Chemerin as a mediator between obesity and vascular inflammation in children. J ClinEndocrinolMetab; 97: E556-564. |
[24] | Altinova A.E., Törüner F.B., Aktürk M., Bukan N. et al., (2006): Adiponectin levels and cardiovascular risk factors in hypothyroidism and hyperthyroidism. Clinical Endocrinology; 65: 530–535. |
[25] | Amin A., Dhillo W.S. and Murphy K.G. (2011): The central effects of thyroid hormones on appetite. J Thyroid Res.; 2011: 306510. |
[26] | Gime´nez-Palop O., Gime´nez-Pe´rez G., Mauricio D. and Berlanga E. (2005): Circulating ghrelin in thyroid dysfunction is related to insulin resistance and not to hunger, food intake or anthropometric changes. European Journal of Endocrinology; 153: 73–79. |
[27] | Alva-Sánchez C., Pacheco-Rosado J., Fregoso-Aguilar T., Villanueva I. (2012): The long-term regulation of food intake and body weight depends on the availability of thyroid hormones in the brain. Neuroendocrinology Letters; 33(7): 703–708. |
[28] | Gong N., Gao C., Chen X., Wang Y. and Tian L. (2018): Adipokine expression and endothelial function in subclinical hypothyroidism rats. Endocrine Connections; 7: 295–304. |
[29] | Guzel S., Seven A., Guzel E.C., Buyuk B., Celebi A. and Aydemir B. (2013): Visfatin, leptin, and TNF-alpha: interrelated adipokines in insulin-resistant clinical and subclinical hypothyroidism. Endocrine Research; 38: 184–194. |
[30] | Li Y., Chang J. and Jiang T. (2017): Serum level of chemerin and bone mineral density in patients with Graves disease. Zhong Nan Da XueXueBao Yi Xue Ban; 42(8): 947-952. |
[31] | Chen Y., Wu X., Wu R., Xiance Sun X. and et al., (2016): Changes in profile of lipids and adipokines in patients with newly diagnosed hypothyroidism and hyperthyroidism. Scientific RepoRts; 6: 26174. |
[32] | Thompson G.R., Soutar A.K., Spengel F.A., Jadhav A., Gavigan S.J., Myant N.B. (1981): Defects of receptor-mediated low density lipoprotein catabolism in homozygous familial hypercholesterolemia and hypothyroidism in vivo. ProcNatlAcadSci USA; 78, 2591–2595. |
[33] | Nikkila, E. A. and Kekki, M. (1972): Plasma triglyceride metabolism in thyroid disease. J Clin Invest; 51: 2103–2114. |
[34] | Shin, D. J. and Osborne, T. F. (2003): Thyroid hormone regulation and cholesterol metabolism are connected through Sterol Regulatory Element-Binding Protein-2 (SREBP-2). J BiolChem; 278: 34114–34118. |